Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07455383 Alixorexton Narcolepsy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07455383 clinical trial report covering Alixorexton, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07455006 Romiplostim Biosimilar (Qilu Pharma) Purpura, Thrombocytopenic, Idiopathic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07455006 clinical trial report covering Romiplostim Biosimilar (Qilu Pharma), Phase 3, endpoints, sponsor, geography, readout timing and development whi
Latest Hotspot
8 min read
NCT07459296 Sintilimab Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07459296 clinical trial report covering Sintilimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07453888 Cenegermin-BKBJ Optic Neuropathy, Ischemic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07453888 clinical trial report covering Cenegermin-BKBJ, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260588 Recombinant human thyroid stimulating hormone(SmartNuclide) Differentiated Thyroid Gland Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260588 clinical trial report covering Recombinant human thyroid stimulating hormone(SmartNuclide), Phase 3, endpoints, sponsor, geography, readout tim
Latest Hotspot
8 min read
JPRN-jRCT2033250788 HLC-001 Ichthyosis Prematurity Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
JPRN-jRCT2033250788 clinical trial report covering HLC-001, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07457918 Cantharidin Condylomata Acuminata Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07457918 clinical trial report covering Cantharidin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07461948 Ferumoxytol Glioblastoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461948 clinical trial report covering Ferumoxytol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07457294 Clascoterone Acne Vulgaris Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07457294 clinical trial report covering Clascoterone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260756 Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences) Meningitis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260756 clinical trial report covering Group ACYW135 Meningococcal Conjugate Vaccine (Sinovac Life Sciences), Phase 3, endpoints, sponsor, geography, r
Latest Hotspot
8 min read
NCT07461441 Faricimab Age Related Macular Degeneration Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461441 clinical trial report covering Faricimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07461454 YL-202 Locally advanced breast cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07461454 clinical trial report covering YL-202, Phase 3, endpoints, sponsor, geography, readout timing and development white space.